Should You Buy BioNTech SE - ADR (BNTX) Stock Friday Morning?

BioNTech SE - ADR (BNTX) is up Friday morning, with the stock rising 1.64% in pre-market trading to 134.46. BNTX's short-term technical score of 19 indicates that the stock has traded less bullishly over the last month than 81% of stocks on the market. In the Biotechnology industry, which ranks 126 out of 146 industries, BioNTech SE - ADR ranks higher than 29% of stocks. BioNTech SE - ADR has fallen 14.38% over the past month, closing at $166.96 on May 27. During this period of time, the stock fell as low as $123.25 and as high as $167.87. BNTX has an average analyst recommendation of Buy. The company has an average price target of $256.09.

BNTX has an Overall Score of 58. Find out what this means to you and get the rest of the rankings on BNTX!

See Full BNTX Report

BioNTech SE - ADR has a Long-Term Technical rank of 66. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 34% of the market scoring higher. In the Biotechnology industry which is number 89 by this metric, BNTX ranks better than 89% of stocks.

Important Dates for Investors in BNTX:

-BioNTech SE - ADR is set to release earnings on 8/8/2022. Over the last 12 months, the company has reported EPS of $-1.04. -We do not have a set dividend date for BioNTech SE - ADR at this time. Click Here To Get The Full Report on BioNTech SE - ADR (BNTX)